Home/Filings/4/0001209191-15-080971
4//SEC Filing

GLOBUS MEDICAL INC 4

Accession 0001209191-15-080971

$GMEDCIK 0001237831operating

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 4:40 PM ET

Size

21.1 KB

Accession

0001209191-15-080971

Insider Transaction Report

Form 4
Period: 2015-11-16
Murphy A Brett
Executive VP, US Sales
Transactions
  • Sale

    Class A Common Stock

    2015-11-16$25.80/sh5,000$129,000116,217 total
Holdings
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $4.88Exp: 2019-08-06Class A Common Stock (9,230 underlying)
    9,230
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $11.87Exp: 2020-06-16Class A Common Stock (9,230 underlying)
    9,230
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $2.93Exp: 2016-11-01Class A Common Stock (107,692 underlying)
    107,692
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $11.28Exp: 2021-04-20Class A Common Stock (15,384 underlying)
    15,384
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $15.34Exp: 2022-08-29Class A Common Stock (10,000 underlying)
    10,000
  • Stock Option (Right to Buy Class A Common Stock

    Exercise: $23.95Exp: 2024-01-23Class A Common Stock (30,000 underlying)
    30,000
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $25.65Exp: 2025-07-07Class A Common Stock (100,000 underlying)
    100,000
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $10.66Exp: 2021-10-27Class A Common Stock (12,307 underlying)
    12,307
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $13.04Exp: 2023-01-24Class A Common Stock (25,000 underlying)
    25,000
  • Stock Option (Right to Buy Class A Common Stock)

    Exercise: $24.10Exp: 2025-01-20Class A Common Stock (50,000 underlying)
    50,000
Footnotes (11)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.75 to $25.81, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  • [F10]These options were granted on January 20, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F11]These options were granted on July 7, 2015, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on July 7, 2016, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F2]These options were granted on November 1, 2006, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on November 1, 2007, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F3]These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F4]These options were granted on June 16, 2010, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2011, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F5]These options were granted on April 20, 2011, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on February 8, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F6]These options were granted on October 27, 2011, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2012, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F7]These options were granted on August 29, 2012, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2013, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F8]These options were granted on January 24, 2013, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
  • [F9]These options were granted on January 23, 2014, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2015, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.

Issuer

GLOBUS MEDICAL INC

CIK 0001237831

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001237831

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 4:40 PM ET
Size
21.1 KB